Dr. Harrington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Office of the Dean
1300 York Avenue, F-113
New York, NY 10065Phone+1 212-746-6005
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1990 - 1993
- UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1989
- Tufts University School of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 2012 - 2025
- NY State Medical License 2023 - 2025
- NC State Medical License 1993 - 2017
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor Start of enrollment: 2006 Apr 01
- Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. Start of enrollment: 2006 Sep 01
- A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome Start of enrollment: 2006 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 396 citationsDarapladib for preventing ischemic events in stable coronary heart disease.Harvey D. White, Claes Held, Ralph A.H. Stewart, Elizabeth Tarka, Rebekkah Brown
The New England Journal of Medicine. 2014-05-01 - 268 citationsDiagnosis and Treatment of Acute Coronary Syndromes: A Review.Deepak L Bhatt, Renato D Lopes, Robert A Harrington
JAMA. 2022-02-15 - 20 citationsAssociations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart diseaseOla Vedin, Emil Hagström, Ollie Östlund, Alvaro Avezum, Andrzej Budaj
International Journal of Cardiology. 2017-10-15
Journal Articles
- Alirocumab and Cardiovascular Outcomes After Acute Coronary SyndromeVera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
- Impact of Lesion Complexity on Peri-Procedural Adverse Events and the Benefit of Potent Intravenous Platelet Adenosine Diphosphate Receptor Inhibition After Percutaneo...Gregg W Stone, Matthew J Price, Philippe Genereux, C Michael Gibson, Deepak L Bhatt, Robert A Harrington, Kenneth W Mahaffey, European Heart Journal
- Effects of Genetic Variation in Protease Activated Receptor 4 After an Acute Coronary Syndrome: Analysis from the TRACER TrialPaolo Fortina, David J Moliterno, Robert A Harrington, Kenneth W Mahaffey, ScienceDirect
Press Mentions
- American Heart Association to Honor 8 Cardiology LeadersNovember 6th, 2024
- SHAPE and I-ELCAP Announce 1st Conference on Integrating Heart and Lung Screening Using Low-Dose CT to Be Held September 19-21, 2024 at the New York Academy of MedicineSeptember 14th, 2024
- This Week in CardiologyMay 24th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: